These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33022587)

  • 41. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.
    Newland PK; Naismith RT; Ullione M
    J Neurosci Nurs; 2009 Dec; 41(6):322-8. PubMed ID: 19998683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.
    Kotterba S; Neusser T; Norenberg C; Bussfeld P; Glaser T; Dörner M; Schürks M
    BMC Neurol; 2018 Aug; 18(1):123. PubMed ID: 30143019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.
    Nicholas JA; Electricwala B; Lee LK; Johnson KM
    BMC Neurol; 2019 Oct; 19(1):258. PubMed ID: 31660897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of multiple sclerosis phenotypes on burden of disease in Finland.
    Purmonen T; Hakkarainen T; Tervomaa M; Ruutiainen J
    J Med Econ; 2020 Feb; 23(2):156-165. PubMed ID: 31617776
    [No Abstract]   [Full Text] [Related]  

  • 47. A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.
    Ghezzi A; Bianchi A; Baroncini D; Bertolotto A; Malucchi S; Bresciamorra V; Lanzillo R; Milani N; Martinelli V; Patti F; Chisari C; Rottoli M; Simone M; Paolicelli D; Visconti A;
    Neurol Sci; 2017 Nov; 38(11):1999-2005. PubMed ID: 28831635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fingolimod for relapsing-remitting multiple sclerosis.
    La Mantia L; Tramacere I; Firwana B; Pacchetti I; Palumbo R; Filippini G
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009371. PubMed ID: 27091121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
    Ziemssen T; Calabrese P; Penner IK; Apfel R
    J Neurol; 2016 Apr; 263(4):784-91. PubMed ID: 26914926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of myofascial trigger points in post-amputation pain: causation and management.
    Reiestad F; Kulkarni J
    Prosthet Orthot Int; 2013 Apr; 37(2):120-3. PubMed ID: 22717467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.
    Kappos L; Gold R; Arnold DL; Bar-Or A; Giovannoni G; Selmaj K; Sarda SP; Agarwal S; Zhang A; Sheikh SI; Seidman E; Dawson KT
    Mult Scler; 2014 Feb; 20(2):243-52. PubMed ID: 24150779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of primary dysmenorrhea among students and its association with musculoskeletal and myofascial pain.
    Yacubovich Y; Cohen N; Tene L; Kalichman L
    J Bodyw Mov Ther; 2019 Oct; 23(4):785-791. PubMed ID: 31733762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study.
    Bertoglio JC; Baumgartner M; Palma R; Ciampi E; Carcamo C; Cáceres DD; Acosta-Jamett G; Hancke JL; Burgos RA
    BMC Neurol; 2016 May; 16():77. PubMed ID: 27215274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial.
    Mousavi-Shirazi-Fard Z; Mazloom Z; Izadi S; Fararouei M
    Int J Neurosci; 2021 Jul; 131(7):657-665. PubMed ID: 32249637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tracking daily fatigue fluctuations in multiple sclerosis: ecological momentary assessment provides unique insights.
    Powell DJH; Liossi C; Schlotz W; Moss-Morris R
    J Behav Med; 2017 Oct; 40(5):772-783. PubMed ID: 28281106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies.
    Kita M; Fox RJ; Gold R; Giovannoni G; Phillips JT; Sarda SP; Kong J; Viglietta V; Sheikh SI; Okwuokenye M; Kappos L
    Clin Ther; 2014 Dec; 36(12):1958-1971. PubMed ID: 25315404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrasound-guided trigger point injections in the cervicothoracic musculature: a new and unreported technique.
    Botwin KP; Sharma K; Saliba R; Patel BC
    Pain Physician; 2008; 11(6):885-9. PubMed ID: 19057634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myofascial pain syndrome and SARS-CoV-2: a case series.
    Patel J; Javed S
    Pain Manag; 2022 Apr; 12(3):255-260. PubMed ID: 34601951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
    Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
    Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.